JP2023552791A5 - - Google Patents

Info

Publication number
JP2023552791A5
JP2023552791A5 JP2023534648A JP2023534648A JP2023552791A5 JP 2023552791 A5 JP2023552791 A5 JP 2023552791A5 JP 2023534648 A JP2023534648 A JP 2023534648A JP 2023534648 A JP2023534648 A JP 2023534648A JP 2023552791 A5 JP2023552791 A5 JP 2023552791A5
Authority
JP
Japan
Prior art keywords
alkyldiyl
peg
alkyl
immunocomplex
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2023534648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023552791A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/062833 external-priority patent/WO2022125915A1/en
Publication of JP2023552791A publication Critical patent/JP2023552791A/ja
Publication of JP2023552791A5 publication Critical patent/JP2023552791A5/ja
Withdrawn legal-status Critical Current

Links

JP2023534648A 2020-12-11 2021-12-10 抗her2免疫複合体、及びその使用 Withdrawn JP2023552791A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063124421P 2020-12-11 2020-12-11
US63/124,421 2020-12-11
PCT/US2021/062833 WO2022125915A1 (en) 2020-12-11 2021-12-10 Anti-her2 immunoconjugates, and uses thereof

Publications (2)

Publication Number Publication Date
JP2023552791A JP2023552791A (ja) 2023-12-19
JP2023552791A5 true JP2023552791A5 (cg-RX-API-DMAC7.html) 2024-12-05

Family

ID=79425413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534648A Withdrawn JP2023552791A (ja) 2020-12-11 2021-12-10 抗her2免疫複合体、及びその使用

Country Status (6)

Country Link
US (1) US20240042050A1 (cg-RX-API-DMAC7.html)
EP (1) EP4259211A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023552791A (cg-RX-API-DMAC7.html)
CN (1) CN116897054A (cg-RX-API-DMAC7.html)
CA (1) CA3200320A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022125915A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3200056A1 (en) 2020-12-11 2022-06-16 Shelley Erin ACKERMAN Anti-her2 immunoconjugates, and uses thereof
WO2023154318A1 (en) * 2022-02-09 2023-08-17 Bolt Biotherapeutics, Inc. Anti-tr0p2, aminobenzazepine immunoconjugates, and uses thereof
WO2024173387A1 (en) 2023-02-14 2024-08-22 Bolt Biotherapeutics, Inc. Aza-benzazepine immunoconjugates, and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・2・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
WO1989006692A1 (en) 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
ATE370961T1 (de) 1998-05-06 2007-09-15 Genentech Inc Reinigung von antikörpern durch ionenaustauschchromatographie
US6949245B1 (en) 1999-06-25 2005-09-27 Genentech, Inc. Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
AU5345901A (en) 2000-04-13 2001-10-30 Univ Rockefeller Enhancement of antibody-mediated immune responses
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
US20070014795A1 (en) 2004-12-30 2007-01-18 Dhodapkar Madhav V Compositions and methods for enhanced dendritic cell maturation and function
AU2006312148B2 (en) 2005-11-07 2012-04-12 The Rockefeller University Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
PE20090245A1 (es) 2007-05-08 2009-03-17 Genentech Inc Anticuerpos anti-muc16 disenados con cisteina y conjugados de anticuerpos y farmacos
BRPI0818780A2 (pt) 2007-10-19 2015-04-22 Genentech Inc Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos
EP2640727B1 (en) 2010-11-17 2015-05-13 Genentech, Inc. Alaninyl maytansinol antibody conjugates
JP6805142B2 (ja) 2014-11-21 2020-12-23 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Cd73に対する抗体およびその使用
EP3849971A2 (en) * 2018-09-12 2021-07-21 Silverback Therapeutics, Inc. Substituted benzazepine compounds, conjugates, and uses thereof
JP2022537158A (ja) * 2019-06-13 2022-08-24 ボルト バイオセラピューティクス、インコーポレーテッド アミノベンズアゼピン化合物、イムノコンジュゲート、及びそれらの使用
EP3983080A1 (en) * 2019-06-13 2022-04-20 Bolt Biotherapeutics, Inc. Macromolecule-supported aminobenzazepine compounds
CA3176626A1 (en) * 2020-05-08 2021-11-11 David Dornan Elastase-substrate, peptide linker immunoconjugates, and uses thereof

Similar Documents

Publication Publication Date Title
JP2023553421A5 (ja) 抗cea免疫複合体、及びその使用
JP2024523453A5 (cg-RX-API-DMAC7.html)
JP2022553702A5 (cg-RX-API-DMAC7.html)
JP2023552792A5 (cg-RX-API-DMAC7.html)
JP2022537158A5 (cg-RX-API-DMAC7.html)
JP2022549510A5 (cg-RX-API-DMAC7.html)
JP2023524271A5 (cg-RX-API-DMAC7.html)
CA3186295A1 (en) Camptothecin drug having high-stability hydrophilic connecting unit and conjugate thereof
JP2023105175A (ja) グルクロニド薬物-リンカーの調製のためのプロセスおよびその中間体
JP2023552790A5 (cg-RX-API-DMAC7.html)
JP2024059609A5 (cg-RX-API-DMAC7.html)
CA2462085C (en) Cytotoxic agents
IL312845B1 (en) Extacan derivatives, charge-linkers, and their conjugates
JP2024501453A5 (cg-RX-API-DMAC7.html)
JP2022546110A5 (cg-RX-API-DMAC7.html)
JP2024533356A5 (cg-RX-API-DMAC7.html)
CA3044898A1 (en) Di-substituted maleic amide linker for antibody-drug conjugating and preparation method and use thereof
JP2023527962A5 (cg-RX-API-DMAC7.html)
RU2748992C2 (ru) Системы доставки для контролируемого высвобождения лекарственного средства
JP2024511088A5 (cg-RX-API-DMAC7.html)
JP2022554094A5 (cg-RX-API-DMAC7.html)
JP2019502650A5 (ja) 抗ErbB2抗体−薬物コンジュゲート及びその組成物、そのための調製方法、並びにその使用
WO2024227439A1 (zh) 具有靶向作用的偶联物及其制备方法和用途
CA2338000C (en) Water-soluble 4-thio-maleimido derivatives and methods for their production
JP2025505638A5 (cg-RX-API-DMAC7.html)